Ignite Creation Date:
2025-12-24 @ 10:14 PM
Ignite Modification Date:
2026-07-21 @ 5:45 PM
Study NCT ID:
NCT05233735
Status:
UNKNOWN
Last Update Posted:
2022-02-10
First Post:
2021-10-05
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Enhanced Transcutaneous Delivery of Betamethasone for the Treatment of Vitiligo
Sponsor:
Tel-Aviv Sourasky Medical Center
Organization:
Organization Data
Organization:
Class:
OTHER_GOV
Study ID:
0853-20
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER_GOV
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None